Publications by authors named "P J Branigan"

IL-23 is a cytokine produced by myeloid cells that drives the T helper 17 pathway and plays an essential role in the pathophysiology of plaque psoriasis. IL-23 activation initiates a cascade of cytokines subsequently inducing the expression of many psoriasis-related proteins. This study aimed to better understand the underlying mechanisms driving the differences between IL-23 and IL-17A blockade in patients with psoriasis and their implications for durability of clinical responses.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is treated by targeting specific immune responses, particularly through the blockade of IL-23 and TNF-α, with research indicating that guselkumab is more effective than adalimumab (ADA) for severe cases.
  • A study comparing the effects of guselkumab and ADA measured inflammatory cytokine levels and skin biopsy results in patients over time to assess their pharmacodynamic responses.
  • Results showed that guselkumab significantly reduced key inflammatory markers and associated genes in patients, maintaining these effects over the treatment period, indicating its superior efficacy in managing psoriasis.
View Article and Find Full Text PDF

Heart disease remains a prominent global health concern, with cardiovascular disease (CVD) standing as a leading cause of death worldwide. Preventing heart disease not only decreases the risk of premature death but also mitigates complications like heart attacks, strokes, and arrhythmias, thereby enhancing overall health and quality of life. The economic burden of heart disease treatment highlights the importance of implementing preventive measures, such as lifestyle changes and early interventions, which can alleviate healthcare costs.

View Article and Find Full Text PDF

Background: Early and accurate identification of acute exacerbations of COPD may lead to earlier treatment and prevent hospital admission. Electronic diaries have been developed for symptom monitoring and accelerometers to monitor activity. However, it is unclear whether this technology is usable in the COPD population.

View Article and Find Full Text PDF